CITIGROUP INC - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$37,317
-87.5%
6,847
-84.6%
0.00%
Q2 2023$298,011
+234.9%
44,413
+340.7%
0.00%
Q1 2023$88,988
-8.5%
10,078
-20.8%
0.00%
Q4 2022$97,242
-3.7%
12,728
-10.1%
0.00%
Q3 2022$101,000
-51.2%
14,157
-44.7%
0.00%
Q2 2022$207,000
-47.5%
25,604
-9.8%
0.00%
Q1 2022$394,000
-42.3%
28,375
+16.6%
0.00%
Q4 2021$683,000
-33.4%
24,328
-19.4%
0.00%
-100.0%
Q3 2021$1,026,000
-29.1%
30,176
-14.9%
0.00%0.0%
Q2 2021$1,448,000
+39.5%
35,446
+37.4%
0.00%0.0%
Q1 2021$1,038,000
-41.3%
25,791
-13.7%
0.00%0.0%
Q4 2020$1,767,000
+15.9%
29,877
-4.7%
0.00%0.0%
Q3 2020$1,524,000
-6.3%
31,338
-6.7%
0.00%0.0%
Q2 2020$1,626,000
-58.3%
33,592
-76.1%
0.00%
-75.0%
Q1 2020$3,901,000
-7.1%
140,434
+0.0%
0.00%
+33.3%
Q4 2019$4,201,000
+183.7%
140,421
+192.9%
0.00%
+200.0%
Q3 2019$1,481,00047,9350.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders